A new immunochemical strategy for triple-negative breast cancer therapy
Abstract Triple-negative breast cancer (TNBC) is a highly diverse group of malignant neoplasms which tend to have poor outcomes, and the development of new targets and strategies to treat these cancers is sorely needed. Antibody–drug conjugate (ADC) therapy has been shown to be a promising targeted...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/65dfaed7185b4b46a02f81c93c98f21c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|